SG11201707592TA - A serotype cross-reactive, dengue neutralizing antibody and uses thereof - Google Patents
A serotype cross-reactive, dengue neutralizing antibody and uses thereofInfo
- Publication number
- SG11201707592TA SG11201707592TA SG11201707592TA SG11201707592TA SG11201707592TA SG 11201707592T A SG11201707592T A SG 11201707592TA SG 11201707592T A SG11201707592T A SG 11201707592TA SG 11201707592T A SG11201707592T A SG 11201707592TA SG 11201707592T A SG11201707592T A SG 11201707592TA
- Authority
- SG
- Singapore
- Prior art keywords
- reactive
- neutralizing antibody
- serotype cross
- dengue neutralizing
- dengue
- Prior art date
Links
- 208000001490 Dengue Diseases 0.000 title 1
- 206010012310 Dengue fever Diseases 0.000 title 1
- 208000025729 dengue disease Diseases 0.000 title 1
- 230000003472 neutralizing effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/18—Togaviridae; Flaviviridae
- G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
- G01N2333/185—Flaviviruses or Group B arboviruses, e.g. yellow fever virus, japanese encephalitis, tick-borne encephalitis, dengue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SG10201502068V | 2015-03-17 | ||
PCT/SG2016/050124 WO2016148653A1 (en) | 2015-03-17 | 2016-03-17 | A serotype cross-reactive, dengue neutralizing antibody and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201707592TA true SG11201707592TA (en) | 2017-10-30 |
Family
ID=56920185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201707592TA SG11201707592TA (en) | 2015-03-17 | 2016-03-17 | A serotype cross-reactive, dengue neutralizing antibody and uses thereof |
Country Status (6)
Country | Link |
---|---|
US (1) | US10316078B2 (he) |
EP (1) | EP3271390B1 (he) |
JP (1) | JP6957355B2 (he) |
CN (1) | CN107531779B (he) |
SG (1) | SG11201707592TA (he) |
WO (1) | WO2016148653A1 (he) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3026050A1 (en) | 2016-08-05 | 2018-02-08 | Chugai Seiyaku Kabushiki Kaisha | Composition for prophylaxis or treatment of il-8 related diseases |
SG10201607778XA (en) * | 2016-09-16 | 2018-04-27 | Chugai Pharmaceutical Co Ltd | Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use |
TWI769185B (zh) * | 2016-10-27 | 2022-07-01 | 海樂源有限公司 | 登革熱類病毒顆粒、抗登革熱病毒抗體、及含其之組合物 |
EP3765494A4 (en) | 2018-03-15 | 2022-03-23 | Chugai Seiyaku Kabushiki Kaisha | ANTI-DENGUE VIRUS ANTIBODIES WITH CROSS-REACTIVITY AGAINST ZIKA VIRUS AND METHODS OF USE |
US10526398B2 (en) * | 2018-06-12 | 2020-01-07 | National Defense Medical Center | Anti-dengue virus antibodies and applications thereof |
TWI737918B (zh) * | 2018-06-12 | 2021-09-01 | 國防醫學院 | 抗登革病毒抗體及其應用 |
CN109929033B (zh) * | 2019-03-15 | 2020-06-02 | 中国人民解放军军事科学院军事医学研究院 | 一种特异性结合四种血清型登革病毒的人源抗体 |
CN115697392A (zh) * | 2020-06-28 | 2023-02-03 | 神州细胞工程有限公司 | 一种降低病毒ade效应的方法 |
JP7286070B2 (ja) * | 2021-01-31 | 2023-06-05 | 株式会社バランス・イースト | 検査システム、検査方法、プログラム、およびコンピュータが読み取り可能な記憶媒体 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6753418B2 (en) | 2000-10-05 | 2004-06-22 | Case Western Reserve University | Suppressors of human breast cancer cell growth |
US8470976B2 (en) | 2006-06-17 | 2013-06-25 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting macromolecules into the nucleus |
EP2160407A4 (en) * | 2007-05-23 | 2011-07-27 | Crc For Asthma And Airways Ltd | NEUTRALIZING ANTIBODIES |
BRPI0914012B1 (pt) * | 2008-10-13 | 2022-02-15 | Institute For Research In Biomedicine | Composição farmacêutica e uso da composição farmacêutica |
KR20160044598A (ko) | 2011-03-29 | 2016-04-25 | 로슈 글리카트 아게 | 항체 Fc 변이체 |
US20140349321A1 (en) * | 2011-12-16 | 2014-11-27 | Agency For Science, Technology And Research | Binding molecules against dengue virus and uses thereof |
US9556254B2 (en) | 2012-05-14 | 2017-01-31 | The Usa, As Represented By The Secretary, Dept. Of Health And Human Services | Cross-reactive antibodies against dengue virus and uses thereof |
CN113817053A (zh) * | 2014-02-11 | 2021-12-21 | 威特拉公司 | 用于登革病毒的抗体分子及其应用 |
-
2016
- 2016-03-17 US US15/558,937 patent/US10316078B2/en active Active
- 2016-03-17 JP JP2017549051A patent/JP6957355B2/ja active Active
- 2016-03-17 CN CN201680027752.4A patent/CN107531779B/zh active Active
- 2016-03-17 SG SG11201707592TA patent/SG11201707592TA/en unknown
- 2016-03-17 EP EP16765356.7A patent/EP3271390B1/en active Active
- 2016-03-17 WO PCT/SG2016/050124 patent/WO2016148653A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
JP6957355B2 (ja) | 2021-11-02 |
EP3271390A4 (en) | 2018-08-08 |
EP3271390B1 (en) | 2023-09-27 |
WO2016148653A1 (en) | 2016-09-22 |
US20180072798A1 (en) | 2018-03-15 |
JP2018514193A (ja) | 2018-06-07 |
CN107531779B (zh) | 2021-04-13 |
EP3271390A1 (en) | 2018-01-24 |
CN107531779A (zh) | 2018-01-02 |
US10316078B2 (en) | 2019-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL264654B1 (he) | נוגדנים נגד tigit, נוגדנים נגד pvrig ושילובים שלהם | |
IL304772A (he) | נוגדנים, שימושים ושיטות | |
HK1247214B (zh) | 一種pdl-1抗體、其藥物組合物及其用途 | |
ZA201701168B (en) | Antibodies, compositions, and uses | |
ZA201704117B (en) | Cd47 antibodies, methods, and uses | |
IL262497A (he) | נוגדנים אנטי-il-33, תכשירים, שיטות ושימושים שלהם | |
IL276695B (he) | נוגדנים, תכשירי רוקחות ושימושים בהם | |
SG11201707592TA (en) | A serotype cross-reactive, dengue neutralizing antibody and uses thereof | |
EP3200823A4 (en) | Multivalent meditopes, meditope-binding antibodies and uses thereof | |
IL244043B (he) | נוגדנים נגד csf–1r ושימוש בהם. | |
IL252430A0 (he) | נוגדנים, שימושים ושיטות | |
GB201614162D0 (en) | Antibodies, uses thereof and conjugates thereof | |
HK1252350A1 (zh) | Mrka多肽、抗體及其用途 | |
PT3288575T (pt) | Complexo de proteína-melanina bioassimilável, sua preparação e utilizações | |
GB201708105D0 (en) | Antibodies, uses thereof and conjugates thereof | |
GB201609866D0 (en) | Antibodies, uses thereof and conjugates thereof | |
IL249073A0 (he) | קומפלקס ציטין-גלוקאן, הכנתו ושימושים בו | |
GB201618515D0 (en) | Combinations comprising antibodies, uses and methods | |
GB201413950D0 (en) | Antibodies, uses & methods | |
GB201400597D0 (en) | Antibodies, uses & methods |